A practical work around for breast density distribution discrepancies between mammographic images from different vendors
- PMID: 39890617
- PMCID: PMC12226699
- DOI: 10.1007/s00330-025-11383-w
A practical work around for breast density distribution discrepancies between mammographic images from different vendors
Abstract
Objectives: Investigate the impact of mammography device grouped by vendor on volumetric breast density and propose a method that mitigates biases when determining the proportion of high-density women.
Materials and methods: Density grade class and volumetric breast density distributions were obtained from mammographic images from three different vendor devices in different centers using breast density evaluation software in a retrospective study. Density distributions were compared across devices with a Mann-Whitney U test and breast density thresholds corresponding to distribution percentiles calculated. A method of matching density percentiles is proposed to determine women at potentially high risk while mitigating possible bias due to the device used for screening.
Results: 2083 (mean age 59 ± 5.4), 531 (mean age 58.8 ± 5.7) and 244 (mean age 60.7 ± 6.0) screened women were evaluated on three vendor devices, respectively. Both the density grade distribution and the volumetric breast density were different between Vendor 1 and Vendor 2 data (p < 0.001) and between Vendor 1 and Vendor 3 data (p < 0.001). Between Vendor 2 and Vendor 3, no significant difference was observed (p = 0.67 for density grade, p = 0.29 for volumetric density). To recruit the top 10% of women with extremely dense breasts required respective density thresholds of 16.1%, 13.6% and 13.8% for the three vendor devices.
Conclusion: Density grade class and volumetric breast density distributions differ between devices grouped by vendor and can result in statistically different breast density distributions. Percentile-dependent density thresholds can ensure unbiased selection of high-risk women.
Key points: Question Does the use of x-ray systems from different vendors influence breast density evaluation and the resulting selection of high-risk women during breast cancer screening? Findings Statistically significant differences were observed between breast density distributions of different vendors; a method of matching via percentiles is proposed to prevent biased density evaluations. Clinical relevance Measured breast density distributions differed between X-ray devices. A workaround is proposed that determines density thresholds corresponding to a specified population, allowing the same proportion of women to be selected with a density algorithm.
Keywords: Breast density; Breast neoplasms; Early detection of cancer; Mammography.
© 2025. The Author(s).
Conflict of interest statement
Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Prof. Dr. Hilde Bosmans. Conflict of interest: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: No complex statistical methods were necessary for this paper. Informed consent: Written informed consent was waived by the Institutional Review Board. Ethical approval: Institutional Review Board approval was obtained. Study subjects or cohorts overlap: No study subjects or cohorts have been previously reported. Methodology: Retrospective Cross-sectional study Multicenter study
Figures




Similar articles
-
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3. Cochrane Database Syst Rev. 2023. PMID: 36999589 Free PMC article.
-
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2. Cochrane Database Syst Rev. 2021. PMID: 34697802 Free PMC article.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Treatments for breast engorgement during lactation.Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD006946. doi: 10.1002/14651858.CD006946.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Sep 18;9:CD006946. doi: 10.1002/14651858.CD006946.pub4. PMID: 27351423 Free PMC article. Updated.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
References
-
- Kerlikowske K (2009) Evidence-based breast cancer prevention: the importance of individual risk. Ann Intern Med 151:750. 10.7326/0003-4819-151-10-200911170-00012 - PubMed
-
- Allweis TM, Hermann N, Berenstein-Molho R, Guindy M (2021) Personalized screening for breast cancer: rationale, present practices, and future directions. Ann Surg Oncol 28:4306–4317. 10.1245/s10434-020-09426-1 - PubMed
-
- Esserman L (2009) Rethinking screening for breast cancer and prostate cancer. JAMA 302:1685. 10.1001/jama.2009.1498 - PubMed
-
- Mandelblatt JS, Stout N, Trentham-Dietz A (2011) To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer? Ann Intern Med 155:58. 10.7326/0003-4819-155-1-201107050-00008 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical